Cargando…
Medullary Thyroid Carcinoma: Targeted Therapies and Future Directions
Medullary thyroid cancer (MTC) is a rare neuroendocrine neoplasm that accounts for approximately 5% of all thyroid malignancies. The natural history of MTC is characterized by early lymph node and distant metastases, making complete surgical cure often impossible. Conventional chemotherapy and exter...
Autores principales: | Pinchot, Scott N., Kunnimalaiyaan, Muthusamy, Sippel, Rebecca S., Chen, Herbert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2798103/ https://www.ncbi.nlm.nih.gov/pubmed/20069043 http://dx.doi.org/10.1155/2009/183031 |
Ejemplares similares
-
Multi-targeted approach in the treatment of thyroid cancer
por: Pinchot, Scott N, et al.
Publicado: (2008) -
Tumor Suppressor Role of Notch1 and Raf-1 Signaling in Medullary Thyroid Cancer Cells
por: Kunnimalaiyaan, Muthusamy, et al.
Publicado: (2007) -
ACTH-producing carcinoma of the pituitary with refractory Cushing's Disease and hepatic metastases: a case report and review of the literature
por: Pinchot, Scott N, et al.
Publicado: (2009) -
The Management of Medullary Thyroid Carcinoma in the Era of Targeted Therapy
por: Ng-Cheng-Hin, Brian, et al.
Publicado: (2016) -
Recent advances in the biology and therapy of medullary thyroid carcinoma
por: Nelkin, Barry
Publicado: (2017)